Restricted accessResearch articleFirst published online 2022-09-20
Repeated ultrasound-guided percutaneous thermal ablation combined with systemic therapy achieves a stable condition in an end-stage patient with more than 10 liver metastases from breast cancer: The importance of sonazoid assisted contrast-enhanced ultrasound and fusion imaging
The liver is one of the most frequent metastatic sites of breast cancer with a relatively poor prognosis. Systemic chemotherapy is an effective treatment but the efficacy is different between the subtypes of breast cancer. Percutaneous thermal ablation is considered to be a minimally invasive and effective local treatment for breast cancer liver metastases (BCLM). This case report described a patient with BCLM who adopted a strategy of systemic chemotherapy and repeated ultrasound (US) -guided percutaneous thermal ablation procedures. The survival time already reached 8 years till now with the metastases well-controlled and acceptable life quality was achieved.
BaleR, PutzerD, SchullianP. Local treatment of breast cancer liver metastasis. Cancers (Basel). 2019;11(9).
5.
MarschnerCA, ZhangL, SchwarzeV, VölckersW, FroelichMF, vonMünchhausen N, et al. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients. Clin Hemorheol Microcirc. 2020;76(4):453–458.
6.
AuerTA, FischerT, GarciaSRM, PenzkoferT, JungEM, HammB, et al. Value of contrast-enhanced ultrasound (CEUS) in Focal Liver Lesions (FLL) with inconclusive findings on cross-sectional imaging. Clin Hemorheol Microcirc. 2020;74(3):327–339.
7.
RennertJ, GrosseJ, EinspielerI, BäumlerW, StroszczynskiC, JungEM. Complementary imaging of ultrasound and PET/CT: A new opportunity? Clin Hemorheol Microcirc2021;79(1):39–54.
8.
WangJY, XuBH, TianLJ, WangY. Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases. Zhonghua Zhong Liu Za Zhi. 2006;28(8):612–616.
9.
GradisharWJ, AndersonBO, AbrahamJ, AftR, AgneseD, et al. Breast cancer, version 3. NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452–478.
10.
SadotE, LeeSY, SofocleousCT, SolomonSB, GonenM, KinghamTP, et al. Hepatic resection or ablation for isolated breast cancer liver metastasis: A case-control study with comparison to medically treated patients. Ann Surg. 2016;264(1):147–154.
11.
XiaoYB, ZhangB, WuYL. Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: A systematic review and meta-analysis. J Zhejiang Univ Sci B. 2018;19(11):829–843.
12.
YanX, NingZY, WangP. Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: A propensity score matching study. Expert Rev Gastroenterol Hepatol. 2021;15(9):1047–1056.
13.
RennertJ, WiesingerI, BeyerLP, SchichoA, StroszczynskiC, WiggermannP, et al. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies. Clin Hemorheol Microcirc. 2019;73(1):73–83.
14.
LiY, BrownRE, MartinRC. Incomplete thermal ablation of hepatocellular carcinoma: Effects on tumor proliferation. J Surg Res. 2013;181(2):250–255.
15.
HakimeA, YevichS, TselikasL, DeschampsF, PetroverD, De BaereT. Percutaneous thermal ablation with ultrasound guidance. Fusion imaging guidance to improve conspicuity of liver metastasis. Cardiovasc Intervent Radiol. 2017;40(5):721–727.
16.
ClevertDA, PaprottkaPM, HelckA, ReiserM, TrummCG. Image fusion in the management of thermal tumor ablation of the liver [J]. Clin Hemorheol Microcirc. 2012;52(2–4):205–216.
17.
YanagisawaK, MoriyasuF, MiyaharaT, YukiM, IijimaH. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33(2):318–325.
18.
Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol. 2008;34(5):824–833.
19.
AlfagemeF, WortsmanX, CatalanoO, RoustanG, CrisanM, CrisanD, et al. European federation of societies for ultrasound in medicine and biology (EFSUMB) position statement on dermatologic ultrasound. Ultraschall Med. 2021;42(1):39–47.
20.
DietrichCF, NolsoeCP, BarrRG, BerzigottiA, BurnsPN, CantisaniVD, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update -WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41(5):562–585.
21.
JiangC, DavalosRV, BischofJC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng. 2015;62(1):4–20.
